Webinars on demand

The roundtable will address digital and computational pathology now and in the near future.

Pathology is changing at a rapid pace. Join a global panel of expert pathologists to discuss the future of the industry.

This virtual interactive case-based expert forum will be discussing NTRK fusion detection and therapeutic management of NTRK fusion driven advanced cancers.

This open forum discussion will include an exploration of clonal hematopoiesis and of measurable residual disease detection in acute myeloid leukemia.

Whilst many NGS workflows are advertised as “end to end”, we believe that the Ion Torrent™ Genexus™ System and assay menu represents the only true end-to-end solution at the market.

Limbal stem cell deficiency (LSCD) is a pathologic condition resulting from dysfunction and/or loss of limbal stem cells (LSCs).

In this webinar, we’ll introduce two European laboratories, which did not use next generation sequencing (NGS) prior to implementing Ion Torrent™ Genexus™ System.

In this webinar, we will review current guidelines and recommendations for MSI testing in solid tumors.

For patients with acute myeloid leukemia (AML) treated with chemotherapy, the contribution of genetic heterogeneity to drug resistance and disease progression has been well-established.

The relevance to understand the entire tumor heterogeneity, its immune environment and contextual relationship requires the spatial quantification of different immune and tumor cells.

The demand for access to less invasive biopsy methods for cancer presents a critical decision for many provider laboratories.

Want to learn how to achieve IHC assays in 30 minutes and multiplex assays in 2.5 hours?